1. Liang H, Fisher ML, Wu C, Ballon C, Sun X, Mills AA. PRMT5/WDR77 enhances the proliferation of squamous cell carcinoma via the p63-p21 axis Cancers, 16, 22, 2024
​
2. Fisher ML, Balinth S, Hwangbo Y, Wu C, Ballon C, Goldberg GL, Mills AA. Cancer-associated fibroblasts promote cancer stemness by inducing expression of the chromatin modifying protein CBX4 in squamous cell carcinoma Carcinogenesis, 18, 44, 485-496, 2023
​
3. Fisher ML, Balinth S, Mills AA. p63 in cancer: Importance and therapeutic opportunities Trends in Cell Biology, 33, 4, 280-292, 2023
​
4. Balinth S, Fisher ML, Hwangbo Y, Wu C, Ballon C, Sun X, Mills AA. EZH2 regulates a SETDB1/p63 axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma. Oncogene 41, 4130-4144, 2022
​
5. Fisher ML, Balinth S, Hwangbo Y, Wu C, Ballon C, Wilkinson J, Goldber GL, Mills AA. BRD4 regulates transcription factor p63 to drive a cancer stem cell phenotype in squamous cell carcinoma. Cancer Research 81, 24, 6246-6258, 2021
​
6. Fisher ML, Balinth S, and Mills, AA. P63-related signaling at a glance. Journal of Cell Science, 133, jcs228015, 2020
​
7. Wang Y, Leonard MK, Snyder DE, Fisher ML, Eckert RL, Kaetzel DM. NME1 drives expansion of melanoma cells with enhanced tumor growth and metastatic properties. Molecular Cancer Research, 17, 1665-1674, 2019
​
8. Fisher ML, Grun D, Adhikary G, Eckert RL. Sulforaphane reduces YAP/∆Np63α signaling to reduce cancer stem cell survival and tumor formation. Oncotarget, 8, 73407-73418, 2017
​
9. Kerr C, Szmacinski H, Fisher ML, Nance B, Lakowicz JR, Akbar A, Keillor JW, Wong TL, Godoy-Ruiz R, Toth EA, Weber DJ, Eckert RL. Transamidase site-targeted compounds alter the conformation of transglutaminase to reduce GTP binding activity and cancer stem cell survival. Oncogene 36, 2981-2990, 2017
​
10. Fisher ML, Adhikary G, Grun D, Kaetzel DM, Eckert RL. The Ezh2 Polycomb Group Protein Drives an Aggressive Phenotype in Melanoma Cancer Stem Cells and is a Target of Diet Derived Sulforaphane. Molecular Carcinogenesis 55, 2024-2036, 2016
​
11. Eckert RL, Fisher ML, Grun D, Adhikary G, Xu W, Kerr C. Transglutaminase as a cancer stem cell survival factor. 10, 947-958, 2015
​
12. Fisher ML, Keillor JW, Xu W, Eckert RL, Kerr C. Type II Transglutaminase is required for epidermal squamous cell carcinoma stem cell survival. Molecular Cancer Research 7, 1083-1094, 2015
​
13. Adhikary G, Grun D, Kerr C, Balasubramanian S, Rorke EA, Vemuri M, Boucher S, Bickenbach JR, Hornyak T, Xu W, Fisher ML, Eckert RL. Identification of a population of squamous cell carcinoma cells with enhanced potential for tumor formation. PLoS One 8, 12, e84324, 2013
